Home
/
Lunai Bioworks Inc.
/
Financials
/
Quarterly
Lunai Bioworks Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Lunai Bioworks Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Mar 31, 2018
$0
May 15, 2018
Q3
2017
Mar 31, 2016
$42.5K
May 15, 2017
Q2
2017
Dec 31, 2015
$42.5K
Feb 14, 2017
Q2
2014
Dec 31, 2013
$32.8K
Aug 14, 2014
Q3
2014
Sep 30, 2013
$925
Nov 13, 2014
Q2
2014
Jun 30, 2013
$31.6K
Aug 14, 2014
Q1
2014
Mar 31, 2013
$31.6K
May 14, 2014
Q2
2014
Dec 31, 2012
$62.8K
Aug 14, 2014
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($1.80M)
Feb 17, 2026
Q1
2026
Sep 30, 2025
$2.82M
Nov 14, 2025
Q3
2025
Mar 31, 2025
$189.2K
May 15, 2025
Q2
2026
Dec 31, 2024
($7.25M)
Feb 17, 2026
Q3
2025
Dec 31, 2024
($7.25M)
May 15, 2025
Q2
2025
Sep 30, 2024
($44.21M)
Feb 19, 2025
Q3
2025
Sep 30, 2024
($44.21M)
May 15, 2025
Q1
2026
Sep 30, 2024
($44.21M)
Nov 14, 2025
Q3
2025
Mar 31, 2024
($58.99M)
May 15, 2025
Q2
2025
Dec 31, 2023
($4.53M)
Feb 19, 2025
Q3
2025
Dec 31, 2023
($4.53M)
May 15, 2025
Q2
2025
Sep 30, 2023
($9.18M)
Feb 19, 2025
Q3
2025
Sep 30, 2023
($9.18M)
May 15, 2025
Q1
2025
Sep 30, 2023
($9.18M)
Feb 19, 2025
Q3
2024
Mar 31, 2023
($4.33M)
Feb 19, 2025
Q3
2024
Dec 31, 2022
($4.46M)
Feb 19, 2025
Q2
2024
Dec 31, 2022
($4.46M)
Feb 14, 2024
Q1
2024
Sep 30, 2022
($7.70M)
Nov 14, 2023
Q2
2024
Sep 30, 2022
($7.70M)
Feb 14, 2024
Q3
2024
Sep 30, 2022
($7.70M)
Feb 19, 2025
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
($1.82M)
Feb 17, 2026
Q1
2026
Sep 30, 2025
($3.31M)
Nov 14, 2025
Q3
2025
Mar 31, 2025
($4.16M)
May 15, 2025
Q2
2026
Dec 31, 2024
($4.55M)
Feb 17, 2026
Q1
2026
Sep 30, 2024
($53.34M)
Nov 14, 2025
Q3
2025
Mar 31, 2024
($51.38M)
May 15, 2025
Q2
2025
Dec 31, 2023
($4.27M)
Feb 19, 2025
Q1
2025
Sep 30, 2023
($8.88M)
Feb 19, 2025
Q3
2024
Mar 31, 2023
($4.06M)
Feb 19, 2025
Q2
2024
Dec 31, 2022
($4.37M)
Feb 14, 2024
Q1
2024
Sep 30, 2022
($7.19M)
Nov 14, 2023
Q3
2023
Mar 31, 2022
($4.03M)
May 12, 2023
Q2
2023
Dec 31, 2021
($6.33M)
Mar 9, 2023
Q1
2023
Sep 30, 2021
($7.50M)
Mar 7, 2023
Q3
2022
Mar 31, 2021
($3.05M)
May 13, 2022
Q2
2022
Dec 31, 2020
($3.31M)
Feb 14, 2022
Q1
2022
Sep 30, 2020
($2.86M)
Nov 15, 2021
Q3
2021
Mar 31, 2020
($3.83M)
May 17, 2021
Q2
2021
Dec 31, 2019
($2.82M)
Feb 16, 2021
Q1
2021
Sep 30, 2019
($2.44M)
Nov 12, 2020